Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Todd Lowther

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Free Radical Biology & Medicine|July 20, 2019
Unraveling the effects of peroxiredoxin 2 nitration; role of C-terminal tyrosine 193Lía M Randall, Joaquín Dalla Rizza, Derek Parsonage, et al.
The Biochemical Journal|April 10, 2009
Mitochondrial peroxiredoxin 3 is more resilient to hyperoxidation than cytoplasmic peroxiredoxinsAndrew G Cox, Andree G Pearson, Juliet M Pullar, et al.
Antioxidants (Basel, Switzerland)|January 27, 2021
Unique Cellular and Biochemical Features of Human Mitochondrial Peroxiredoxin 3 Establish the Molecular Basis for Its Specific Reaction with ThiostreptonKimberly J Nelson, Terri Messier, Stephanie Milczarek, et al.
Molecular Pharmaceutics|January 30, 2016
Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell LinesTanner K Hill, Amanda L Davis, Frances B Wheeler, et al.
Nature Chemical Biology|September 5, 2018
Chemical proteomics reveals new targets of cysteine sulfinic acid reductaseSalma Akter, Ling Fu, Youngeun Jung, et al.
The Journal of Biological Chemistry|December 15, 2015
Crystal Structure and Substrate Specificity of Human Thioesterase 2: INSIGHTS INTO THE MOLECULAR BASIS FOR THE MODULATION OF FATTY ACID SYNTHASEMelissa K Ritchie, Lynnette C Johnson, Jill E Clodfelter, et al.
Biochimica Et Biophysica Acta|December 15, 2015
Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenaseXingsheng Li, John Knight, Sonia Fargue, et al.
Antioxidants (Basel, Switzerland)|January 6, 2019
Peroxiredoxins in Cancer and Response to Radiation TherapiesTom E Forshaw, Reetta Holmila, Kimberly J Nelson, et al.
Methods in Enzymology|June 2, 2010
Use of dimedone-based chemical probes for sulfenic acid detection evaluation of conditions affecting probe incorporation into redox-sensitive proteinsChananat Klomsiri, Kimberly J Nelson, Erika Bechtold, et al.
Science Advances|October 31, 2025
Mechanism-based peroxiredoxin 3 inhibitors exploit a covalent warhead for cancer therapyKimberly J Nelson, Terrence L Smalley, Terri Messier, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Free Radical Biology & Medicine|July 20, 2019
Unraveling the effects of peroxiredoxin 2 nitration; role of C-terminal tyrosine 193Lía M Randall, Joaquín Dalla Rizza, Derek Parsonage, et al.
The Biochemical Journal|April 10, 2009
Mitochondrial peroxiredoxin 3 is more resilient to hyperoxidation than cytoplasmic peroxiredoxinsAndrew G Cox, Andree G Pearson, Juliet M Pullar, et al.
Antioxidants (Basel, Switzerland)|January 27, 2021
Unique Cellular and Biochemical Features of Human Mitochondrial Peroxiredoxin 3 Establish the Molecular Basis for Its Specific Reaction with ThiostreptonKimberly J Nelson, Terri Messier, Stephanie Milczarek, et al.
Molecular Pharmaceutics|January 30, 2016
Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell LinesTanner K Hill, Amanda L Davis, Frances B Wheeler, et al.
Nature Chemical Biology|September 5, 2018
Chemical proteomics reveals new targets of cysteine sulfinic acid reductaseSalma Akter, Ling Fu, Youngeun Jung, et al.
The Journal of Biological Chemistry|December 15, 2015
Crystal Structure and Substrate Specificity of Human Thioesterase 2: INSIGHTS INTO THE MOLECULAR BASIS FOR THE MODULATION OF FATTY ACID SYNTHASEMelissa K Ritchie, Lynnette C Johnson, Jill E Clodfelter, et al.
Biochimica Et Biophysica Acta|December 15, 2015
Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenaseXingsheng Li, John Knight, Sonia Fargue, et al.
Antioxidants (Basel, Switzerland)|January 6, 2019
Peroxiredoxins in Cancer and Response to Radiation TherapiesTom E Forshaw, Reetta Holmila, Kimberly J Nelson, et al.
Methods in Enzymology|June 2, 2010
Use of dimedone-based chemical probes for sulfenic acid detection evaluation of conditions affecting probe incorporation into redox-sensitive proteinsChananat Klomsiri, Kimberly J Nelson, Erika Bechtold, et al.
Science Advances|October 31, 2025
Mechanism-based peroxiredoxin 3 inhibitors exploit a covalent warhead for cancer therapyKimberly J Nelson, Terrence L Smalley, Terri Messier, et al.
Pageof 5